ÂÜÀòÂÒÂ×

Andrew Karazim is an accomplished executive in the pharmaceutical industry, currently serving as the Chief Commercial Officer at Aprecia Pharmaceuticals since November 2023. Prior experience includes leading US Market Access, Trade, and Specialty at Kaléo from January 2021 to November 2023, where Andrew was responsible for the company's market access strategy and team leadership across various sectors, including government payers and specialty pharmacy networks. Prior to Kaléo, Andrew held senior roles at Abbott and Eli Lilly and Company, including Senior Director of Global Market Access and Customer Facing Capabilities, demonstrating expertise in strategic execution across global markets. Andrew holds a BA in International Business from Yale University and an MBA in Pharmaceutical Marketing from Saint Joseph's University.